Sarepta Therapeutics, Inc.
SRPT· Nasdaq
Filed Mar 15, 2011 · 10-K · 74 days after period end · 0001193125-11-066190
derived · Computed from the longer spans the company filed.
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2010 · filed Mar 15, 2011 · 74 d after period end
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR